| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
|
2015
|
4.33
|
|
2
|
Promotion of rapid testing for HIV in primary care (RHIVA2): a cluster-randomised controlled trial.
|
2015
|
3.36
|
|
3
|
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial.
|
2014
|
2.92
|
|
4
|
Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis.
|
2015
|
2.82
|
|
5
|
DMPA use and HIV acquisition: time to switch to NET-EN?
|
2015
|
2.69
|
|
6
|
Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
|
2016
|
2.35
|
|
7
|
Recruiting male partners for couple HIV testing and counselling in Malawi's option B+ programme: an unblinded randomised controlled trial.
|
2015
|
2.29
|
|
8
|
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial.
|
2015
|
2.23
|
|
9
|
Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial.
|
2015
|
2.17
|
|
10
|
AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study.
|
2015
|
2.09
|
|
11
|
Are randomised controlled trials always required?
|
2015
|
1.99
|
|
12
|
Effect of pre-exposure prophylaxis and combination HIV prevention for men who have sex with men in the UK: a mathematical modelling study.
|
2016
|
1.95
|
|
13
|
The immediate eff ect of the Same-Sex Marriage Prohibition Act on stigma, discrimination, and engagement on HIV prevention and treatment services in men who have sex with men in Nigeria: analysis of prospective data from the TRUST cohort.
|
2015
|
1.92
|
|
14
|
Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA study.
|
2014
|
1.88
|
|
15
|
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study.
|
2015
|
1.85
|
|
16
|
A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study.
|
2016
|
1.85
|
|
17
|
Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis.
|
2015
|
1.80
|
|
18
|
Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis.
|
2015
|
1.77
|
|
19
|
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
|
2015
|
1.76
|
|
20
|
Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.
|
2015
|
1.75
|
|
21
|
Linkage to and engagement in HIV care in western Kenya: an observational study using population-based estimates from home-based counselling and testing.
|
2015
|
1.72
|
|
22
|
Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population.
|
2014
|
1.71
|
|
23
|
Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study.
|
2015
|
1.71
|
|
24
|
Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study.
|
2015
|
1.70
|
|
25
|
Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial.
|
2015
|
1.67
|
|
26
|
Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
|
2015
|
1.64
|
|
27
|
Conditional cash transfers and uptake of and retention in prevention of mother-to-child HIV transmission care: a randomised controlled trial.
|
2016
|
1.63
|
|
28
|
Migration, sexual behaviour, and HIV risk: a general population cohort in rural South Africa.
|
2015
|
1.63
|
|
29
|
Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study.
|
2015
|
1.62
|
|
30
|
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.
|
2015
|
1.61
|
|
31
|
Effect of a clinical decision support system on early action on immunological treatment failure in patients with HIV in Kenya: a cluster randomised controlled trial.
|
2015
|
1.57
|
|
32
|
Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mbarara district, Uganda: a prospective, observational intervention study.
|
2014
|
1.56
|
|
33
|
Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.
|
2015
|
1.55
|
|
34
|
Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study.
|
2015
|
1.55
|
|
35
|
Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.
|
2015
|
1.53
|
|
36
|
Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial.
|
2015
|
1.53
|
|
37
|
Temporal trends in HIV-1 incidence and risk behaviours in men who have sex with men in Bangkok, Thailand, 2006-13: an observational study.
|
2015
|
1.52
|
|
38
|
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial.
|
2016
|
1.52
|
|
39
|
HIV care continuum in Rwanda: a cross-sectional analysis of the national programme.
|
2015
|
1.52
|
|
40
|
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015.
|
2016
|
1.51
|
|
41
|
Effect of the US National HIV/AIDS Strategy targets for improved HIV care engagement: a modelling study.
|
2016
|
1.51
|
|
42
|
The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: a mathematical modelling study.
|
2016
|
1.51
|
|
43
|
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial.
|
2015
|
1.49
|
|
44
|
The Spear and Shield intervention to increase the availability and acceptability of voluntary medical male circumcision in Zambia: a cluster randomised controlled trial.
|
2015
|
1.49
|
|
45
|
Virological failure in patients with HIV-1 subtype C receiving antiretroviral therapy: an analysis of a prospective national cohort in Sweden.
|
2016
|
1.48
|
|
46
|
Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study.
|
2015
|
1.48
|
|
47
|
CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.
|
2015
|
1.47
|
|
48
|
Estimation of mortality among HIV-infected people on antiretroviral treatment in east Africa: a sampling based approach in an observational, multisite, cohort study.
|
2015
|
1.47
|
|
49
|
Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.
|
2016
|
1.47
|
|
50
|
Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
|
2015
|
1.47
|